Form D · Pharmaceuticals
PEPTIVIR, INC.
Aurora, CO · CIK 0001505149
Offering snapshot reported Nov 18, 2010 · SEC filing
- Reported sold
- $300K Offering amount: $300K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $300K Reported outside-investor minimum
- First sale
- Sep 16, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 18, 2010 | Initial | $300,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-150729
Convertible Promissory Notes and the equity issuable upon the conversion thereof
Source: Form D, filed Nov 18, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard C. Duke | Director |
| Robert S. Hodges | Director, Executive |
| Kathryn V. Holmes | Director, Executive |
| Kevin Smith | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
12635 East Montview Blvd. Suite 127
Aurora, CO, 80045
Aurora, CO, 80045